FDA has approved Cerus Corp.’s Intercept Blood System to kill a wide range of pathogens when preparing plasma and platelet transfusions.
The system is the first of its kind that can be used by infusion centers to reduce the risk of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?